Ninety One (UK)’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-415,302
| Closed | -$46.6M | – | 244 |
|
2020
Q2 | $46.6M | Sell |
415,302
-1,353,569
| -77% | -$152M | 0.17% | 103 |
|
2020
Q1 | $159M | Sell |
1,768,871
-176,515
| -9% | -$15.8M | 0.67% | 44 |
|
2019
Q4 | $210M | Sell |
1,945,386
-58,896
| -3% | -$6.37M | 0.7% | 45 |
|
2019
Q3 | $196M | Buy |
2,004,282
+1,355,775
| +209% | +$133M | 0.76% | 38 |
|
2019
Q2 | $221M | Sell |
648,507
-1,024,997
| -61% | -$350M | 0.84% | 36 |
|
2019
Q1 | $226M | Buy |
1,673,504
+240,014
| +17% | +$32.4M | 0.9% | 28 |
|
2018
Q4 | $140M | Buy |
1,433,490
+66,288
| +5% | +$6.45M | 0.6% | 58 |
|
2018
Q3 | $190M | Buy |
1,367,202
+818,204
| +149% | +$114M | 0.71% | 47 |
|
2018
Q2 | $68.2M | Buy |
548,998
+82,961
| +18% | +$10.3M | 0.34% | 84 |
|
2018
Q1 | $51.9M | Sell |
466,037
-237,166
| -34% | -$26.4M | 0.28% | 89 |
|
2017
Q4 | $84.1M | Buy |
+703,203
| New | +$84.1M | 0.35% | 77 |
|